Medicinal Products

Rixathon

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Rixathon
Active Substance rituksimab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01FA01
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for healthcare professionals
Kartica upozorenja za zdravstvene radnike Rixathon, verzija 1, 10
Knjižica za zdravstvene radnike, verzija 5
Kartica upozorenja za zdravstvene radnike za lijek Rixathon (paralelni promet), verzija 1, veljača 2024
Educational materials
for patients / caregivers
Priručnik za bolesnike, verzija 5
Back